In-vitro modeling of TKI resistance in the high-risk B-cell acute lymphoblastic leukemia fusion gene RANBP2-ABL1 - implications for targeted therapy-Reference-Cited by-同舟云学术

In-vitro modeling of TKI resistance in the high-risk B-cell acute lymphoblastic leukemia fusion gene RANBP2-ABL1 - implications for targeted therapy

Published:2021-01-02 Issue:5 Volume:62 Page:1157-1166
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Heatley Susan L.¹²³^ORCID,Asari Kartini¹²,Schutz Caitlin E.¹,Leclercq Tamara M.¹,McClure Barbara J.¹²^ORCID,Eadie Laura N.¹²^ORCID,Hughes Timothy P.¹²⁴⁵^ORCID,Yeung David T.¹²⁴⁵,White Deborah L.¹²³⁶⁷^ORCID

Affiliation:

1. Cancer Program, Precision Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia

2. Discipline of Medicine, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia

3. Australian and New Zealand Children’s Oncology/Haematology Group (ANZCHOG), Melbourne, Australia

4. Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, Australia

5. Australasian Leukaemia and Lymphoma Group, Melbourne, Australia

6. Australian Genomics Health Alliance, Melbourne, Australia

7. Discipline of Paediatrics, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia

Funder

Disclosure statement

National Health and Medical Research Council

Leukemia Foundation, Australia

Cancer Council of South Australia

Beat Cancer

Melissa White Memorial PhD Scholarship

Statewide Super Research Scholarship

Beat Cancer Top-up Scholarship

Peter Nelson Leukemia Research Fellow

NHMRC Early Career

NHMRC RD Wright Fellow

Beat Cancer Principal Research Fellow

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1861275

Reference44 articles.

1. A revised definition for cure of childhood acute lymphoblastic leukemia

2. Survival of Adults with Acute Lymphoblastic Leukemia in Germany and the United States

3. Improving outcomes for high-risk ALL: Translating new discoveries into clinical care

4. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ponatinib: An update on its drug targets, therapeutic potential and safety;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-09